Investigation Overview
January 3, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Seattle Genetics, Inc. (NASDAQ:SGEN) shares over potential securities laws violations by Seattle Genetics and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the sec...
You must register (for free) or login to view the entire investigation.